363 related articles for article (PubMed ID: 16893176)
1. Conversion of protein farnesyltransferase to a geranylgeranyltransferase.
Terry KL; Casey PJ; Beese LS
Biochemistry; 2006 Aug; 45(32):9746-55. PubMed ID: 16893176
[TBL] [Abstract][Full Text] [Related]
2. Crystallographic analysis of CaaX prenyltransferases complexed with substrates defines rules of protein substrate selectivity.
Reid TS; Terry KL; Casey PJ; Beese LS
J Mol Biol; 2004 Oct; 343(2):417-33. PubMed ID: 15451670
[TBL] [Abstract][Full Text] [Related]
3. Reaction path of protein farnesyltransferase at atomic resolution.
Long SB; Casey PJ; Beese LS
Nature; 2002 Oct; 419(6907):645-50. PubMed ID: 12374986
[TBL] [Abstract][Full Text] [Related]
4. Cocrystal structure of protein farnesyltransferase complexed with a farnesyl diphosphate substrate.
Long SB; Casey PJ; Beese LS
Biochemistry; 1998 Jul; 37(27):9612-8. PubMed ID: 9657673
[TBL] [Abstract][Full Text] [Related]
5. Targeted reengineering of protein geranylgeranyltransferase type I selectivity functionally implicates active-site residues in protein-substrate recognition.
Gangopadhyay SA; Losito EL; Hougland JL
Biochemistry; 2014 Jan; 53(2):434-46. PubMed ID: 24344934
[TBL] [Abstract][Full Text] [Related]
6. Enzymology and biology of CaaX protein prenylation.
Fu HW; Casey PJ
Recent Prog Horm Res; 1999; 54():315-42; discussion 342-3. PubMed ID: 10548882
[TBL] [Abstract][Full Text] [Related]
7. Inactivation of farnesyltransferase and geranylgeranyltransferase I by caspase-3: cleavage of the common alpha subunit during apoptosis.
Kim KW; Chung HH; Chung CW; Kim IK; Miura M; Wang S; Zhu H; Moon KD; Rha GB; Park JH; Jo DG; Woo HN; Song YH; Kim BJ; Yuan J; Jung YK
Oncogene; 2001 Jan; 20(3):358-66. PubMed ID: 11313965
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and characterization of piperazinedione-based dual protein inhibitors for both farnesyltransferase and geranylgeranyltransferase-I.
Qiao Y; Gao J; Qiu Y; Wu L; Guo F; Lo KK; Li D
Eur J Med Chem; 2011 Jun; 46(6):2264-73. PubMed ID: 21440964
[TBL] [Abstract][Full Text] [Related]
9. Biochemical and structural studies with prenyl diphosphate analogues provide insights into isoprenoid recognition by protein farnesyl transferase.
Turek-Etienne TC; Strickland CL; Distefano MD
Biochemistry; 2003 Apr; 42(13):3716-24. PubMed ID: 12667062
[TBL] [Abstract][Full Text] [Related]
10. Genetic evidence for in vivo cross-specificity of the CaaX-box protein prenyltransferases farnesyltransferase and geranylgeranyltransferase-I in Saccharomyces cerevisiae.
Trueblood CE; Ohya Y; Rine J
Mol Cell Biol; 1993 Jul; 13(7):4260-75. PubMed ID: 8321228
[TBL] [Abstract][Full Text] [Related]
11. Farnesyltransferase and geranylgeranyltransferase I: structures, mechanism, inhibitors and molecular modeling.
Shen M; Pan P; Li Y; Li D; Yu H; Hou T
Drug Discov Today; 2015 Feb; 20(2):267-76. PubMed ID: 25450772
[TBL] [Abstract][Full Text] [Related]
12. Thematic review series: lipid posttranslational modifications. Structural biology of protein farnesyltransferase and geranylgeranyltransferase type I.
Lane KT; Beese LS
J Lipid Res; 2006 Apr; 47(4):681-99. PubMed ID: 16477080
[TBL] [Abstract][Full Text] [Related]
13. Amino acid residues that define both the isoprenoid and CAAX preferences of the Saccharomyces cerevisiae protein farnesyltransferase. Creating the perfect farnesyltransferase.
Caplin BE; Ohya Y; Marshall MS
J Biol Chem; 1998 Apr; 273(16):9472-9. PubMed ID: 9545274
[TBL] [Abstract][Full Text] [Related]
14. Kinetic analysis of zinc ligand mutants of mammalian protein farnesyltransferase.
Fu HW; Beese LS; Casey PJ
Biochemistry; 1998 Mar; 37(13):4465-72. PubMed ID: 9521766
[TBL] [Abstract][Full Text] [Related]
15. [Inhibitors of isoprenylation of ras p21].
Yoshimatsu K
Gan To Kagaku Ryoho; 1997 Sep; 24(11):1495-502. PubMed ID: 9309147
[TBL] [Abstract][Full Text] [Related]
16. Protein prenylation in an insect cell-free protein synthesis system and identification of products by mass spectrometry.
Suzuki T; Ito M; Ezure T; Shikata M; Ando E; Utsumi T; Tsunasawa S; Nishimura O
Proteomics; 2007 Jun; 7(12):1942-50. PubMed ID: 17514686
[TBL] [Abstract][Full Text] [Related]
17. Theoretical studies on binding and specificity mechanisms of farnesyltransferase (FTase) and geranylgeranyltransferase type-I (GGTase-I) inhibitors by molecular modeling.
Zhou S
Comb Chem High Throughput Screen; 2014; 17(6):509-19. PubMed ID: 24444014
[TBL] [Abstract][Full Text] [Related]
18. Molecular dynamics simulations on the critical states of the farnesyltransferase enzyme.
Sousa SF; Fernandes PA; Ramos MJ
Bioorg Med Chem; 2009 May; 17(9):3369-78. PubMed ID: 19369081
[TBL] [Abstract][Full Text] [Related]
19. Selective modification of CaaX peptides with ortho-substituted anilinogeranyl lipids by protein farnesyl transferase: competitive substrates and potent inhibitors from a library of farnesyl diphosphate analogues.
Troutman JM; Subramanian T; Andres DA; Spielmann HP
Biochemistry; 2007 Oct; 46(40):11310-21. PubMed ID: 17854205
[TBL] [Abstract][Full Text] [Related]
20. Exploiting the substrate tolerance of farnesyltransferase for site-selective protein derivatization.
Nguyen UT; Cramer J; Gomis J; Reents R; Gutierrez-Rodriguez M; Goody RS; Alexandrov K; Waldmann H
Chembiochem; 2007 Mar; 8(4):408-23. PubMed ID: 17279592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
